# Eightco Holdings Inc.: financial statements, quarterly

ORBS · Nasdaq · CIK 1892492 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/orbs.md) · [Financials](/companies/orbs/financials.md) · [Filings](/companies/orbs/filings.md) · [Insiders](/companies/orbs/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/orbs/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [23.3](/filings/0001493152-24-046025.md) | [7.8 d](/filings/0001641172-25-004802.md) | [8.0](/filings/0001641172-25-011052.md) | [5.3](/filings/0001493152-25-012159.md) | [6.1](/filings/0001493152-25-023549.md) | [20.3 d](/filings/0001493152-26-016664.md) | [9.9](/filings/0001493152-26-023890.md) | [7.6](/filings/0001493152-26-036637.md) | [5.3](/filings/0001493152-25-023549.md) | [10.2 d](/filings/0001493152-26-016664.md) | [7.6](/filings/0001493152-26-023890.md) | [2.1](/filings/0001493152-26-036637.md) |
| Cost of revenue | $m | [20.6](/filings/0001493152-24-046025.md) | [8.6 d](/filings/0001641172-25-004802.md) | [6.6](/filings/0001641172-25-011052.md) | [4.0](/filings/0001493152-25-012159.md) | [4.5](/filings/0001493152-25-023549.md) | [18.7 d](/filings/0001493152-26-016664.md) | [9.1](/filings/0001493152-26-023890.md) | [6.3](/filings/0001493152-26-036637.md) | [5.5](/filings/0001493152-25-023549.md) | [11.5 d](/filings/0001493152-26-016664.md) | [7.3](/filings/0001493152-26-023890.md) | [2.0](/filings/0001493152-26-036637.md) |
| Gross profit | $m | [2.7](/filings/0001493152-24-046025.md) | [(0.8) d](/filings/0001641172-25-004802.md) | [1.4](/filings/0001641172-25-011052.md) | [1.3](/filings/0001493152-25-012159.md) | [1.6](/filings/0001493152-25-023549.md) | [1.7 d](/filings/0001493152-26-016664.md) | [0.8](/filings/0001493152-26-023890.md) | [1.2](/filings/0001493152-26-036637.md) | [(0.2)](/filings/0001493152-25-023549.md) | [(1.3) d](/filings/0001493152-26-016664.md) | [0.2](/filings/0001493152-26-023890.md) | [0.1](/filings/0001493152-26-036637.md) |
| Selling, general and administrative | $m | [3.2](/filings/0001493152-24-046025.md) | [2.6 d](/filings/0001641172-25-004802.md) | [3.1](/filings/0001641172-25-011052.md) | [2.2](/filings/0001493152-25-012159.md) | [3.4](/filings/0001493152-25-023549.md) | [3.1 d](/filings/0001493152-26-016664.md) | [2.2](/filings/0001493152-26-023890.md) | [2.5](/filings/0001493152-26-036637.md) | [6.0](/filings/0001493152-25-023549.md) | [13.2 d](/filings/0001493152-26-016664.md) | [10.7](/filings/0001493152-26-023890.md) | [6.7](/filings/0001493152-26-036637.md) |
| Operating income | $m | [(0.7)](/filings/0001493152-24-046025.md) | [(3.7) d](/filings/0001641172-25-004802.md) | [(3.2)](/filings/0001641172-25-011052.md) | [(0.9)](/filings/0001493152-25-012159.md) | [(1.8)](/filings/0001493152-25-023549.md) | [(1.5) d](/filings/0001493152-26-016664.md) | [(1.4)](/filings/0001493152-26-023890.md) | [(1.2)](/filings/0001493152-26-036637.md) | [(6.2)](/filings/0001493152-25-023549.md) | [(48.4) d](/filings/0001493152-26-016664.md) | [(10.5)](/filings/0001493152-26-023890.md) | [(11.8)](/filings/0001493152-26-036637.md) |
| Interest expense | $m | [0.2](/filings/0001493152-23-041316.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | not reported | not reported | not reported | not reported | not reported | not reported | [(0.0)](/filings/0001493152-26-023890.md) | [0.0 d](/filings/0001493152-26-036637.md) | [0.0 d](/filings/0001493152-25-023549.md) | [0.0 d](/filings/0001493152-26-016664.md) | not reported | not reported |
| Net income | $m | [(3.5)](/filings/0001493152-24-046025.md) | [(6.2) d](/filings/0001641172-25-004802.md) | [1.9](/filings/0001641172-25-011052.md) | [4.4](/filings/0001493152-25-012159.md) | [(3.2)](/filings/0001493152-25-023549.md) | [(2.5) d](/filings/0001493152-26-016664.md) | [(2.5)](/filings/0001493152-26-036637.md) | [(1.2)](/filings/0001493152-26-036637.md) | [(25.8)](/filings/0001493152-25-023549.md) | [(232) d](/filings/0001493152-26-016664.md) | [(76.1)](/filings/0001493152-26-036637.md) | [17.7](/filings/0001493152-26-036637.md) |
| Diluted EPS | $ per share | [(4.96)](/filings/0001493152-24-046025.md) | not reported | [1.42](/filings/0001641172-25-011052.md) | [2.15](/filings/0001493152-25-012159.md) | [(1.77)](/filings/0001493152-25-023549.md) | not reported | [(0.84)](/filings/0001493152-26-023890.md) | [(0.38)](/filings/0001493152-26-036637.md) | [(0.58)](/filings/0001493152-25-023549.md) | not reported | [(0.32)](/filings/0001493152-26-023890.md) | [0.04](/filings/0001493152-26-036637.md) |
| Basic EPS | $ per share | [(4.96)](/filings/0001493152-24-046025.md) | not reported | [1.95](/filings/0001641172-25-011052.md) | [2.55](/filings/0001493152-25-012159.md) | [(1.77)](/filings/0001493152-25-023549.md) | not reported | [(0.84)](/filings/0001493152-26-023890.md) | [(0.38)](/filings/0001493152-26-036637.md) | [(0.58)](/filings/0001493152-25-023549.md) | not reported | [(0.32)](/filings/0001493152-26-023890.md) | [0.04](/filings/0001493152-26-036637.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [3.7](/filings/0001493152-23-041316.md) | [5.2](/filings/0001641172-25-004802.md) | [0.8](/filings/0001493152-24-032436.md) | [0.4](/filings/0001493152-24-032440.md) | [2.4](/filings/0001493152-24-046025.md) | [0.2](/filings/0001493152-26-016664.md) | [0.4](/filings/0001641172-25-011052.md) | [0.7](/filings/0001493152-25-012159.md) | [23.7](/filings/0001493152-25-023549.md) | [58.5](/filings/0001493152-26-036637.md) | [7.5](/filings/0001493152-26-023890.md) | [11.0](/filings/0001493152-26-036637.md) |
| Current assets | $m | [17.8](/filings/0001493152-23-041316.md) | [14.7](/filings/0001641172-25-004802.md) | [9.4](/filings/0001493152-24-032436.md) | [8.2](/filings/0001493152-24-032440.md) | [9.6](/filings/0001493152-24-046025.md) | [12.5](/filings/0001493152-26-016664.md) | [9.8](/filings/0001641172-25-011052.md) | [9.1](/filings/0001493152-25-012159.md) | [317](/filings/0001493152-25-023549.md) | [245](/filings/0001493152-26-036637.md) | [225](/filings/0001493152-26-023890.md) | [291](/filings/0001493152-26-036637.md) |
| Total assets | $m | [60.3](/filings/0001493152-24-046025.md) | [55.4](/filings/0001641172-25-004802.md) | [50.2](/filings/0001641172-25-011052.md) | [48.4](/filings/0001493152-25-012159.md) | [49.2](/filings/0001493152-25-023549.md) | [50.8](/filings/0001493152-26-016664.md) | [47.6](/filings/0001641172-25-011052.md) | [48.7](/filings/0001493152-25-012159.md) | [356](/filings/0001493152-25-023549.md) | [250](/filings/0001493152-26-036637.md) | [341](/filings/0001493152-26-023890.md) | [407](/filings/0001493152-26-036637.md) |
| Current liabilities | $m | [26.0](/filings/0001493152-23-041316.md) | [39.5](/filings/0001641172-25-004802.md) | [32.5](/filings/0001493152-24-032436.md) | [25.8](/filings/0001493152-24-032440.md) | [27.2](/filings/0001493152-24-046025.md) | [29.8](/filings/0001493152-26-016664.md) | [28.7](/filings/0001641172-25-011052.md) | [30.4](/filings/0001493152-25-012159.md) | [16.8](/filings/0001493152-25-023549.md) | [18.0](/filings/0001493152-26-036637.md) | [18.3](/filings/0001493152-26-023890.md) | [13.4](/filings/0001493152-26-036637.md) |
| Total liabilities | $m | [57.6](/filings/0001493152-23-041316.md) | [59.8](/filings/0001641172-25-004802.md) | [46.8](/filings/0001493152-24-032436.md) | [34.9](/filings/0001493152-24-032440.md) | [36.6](/filings/0001493152-24-046025.md) | [39.3](/filings/0001493152-26-016664.md) | [38.3](/filings/0001641172-25-011052.md) | [40.2](/filings/0001493152-25-012159.md) | [16.8](/filings/0001493152-25-023549.md) | [18.0](/filings/0001493152-26-036637.md) | [18.3](/filings/0001493152-26-023890.md) | [13.4](/filings/0001493152-26-036637.md) |
| Current portion of debt | $m | not reported | not reported | [11.5](/filings/0001493152-24-032436.md) | [11.5](/filings/0001493152-24-032440.md) | [11.5](/filings/0001493152-24-046025.md) | not reported | [11.5](/filings/0001641172-25-011052.md) | [11.5](/filings/0001493152-25-012159.md) | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [3.0](/filings/0001493152-23-041316.md) | [(3.9)](/filings/0001641172-25-004802.md) | [3.9](/filings/0001493152-24-032436.md) | [13.8](/filings/0001493152-24-032440.md) | [13.0](/filings/0001493152-24-046025.md) | [11.9](/filings/0001493152-26-016664.md) | [9.7](/filings/0001641172-25-011052.md) | [8.9](/filings/0001493152-25-012159.md) | [339](/filings/0001493152-25-023549.md) | [233](/filings/0001493152-26-036637.md) | [323](/filings/0001493152-26-023890.md) | [394](/filings/0001493152-26-036637.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(1,026) d](/filings/0001493152-24-046025.md) | [299 d](/filings/0001641172-25-004802.md) | [(723)](/filings/0001641172-25-011052.md) | [(440) d](/filings/0001493152-25-012159.md) | [77.7 d](/filings/0001493152-25-023549.md) | [(5,551) d](/filings/0001493152-26-016664.md) | [1,000](/filings/0001493152-26-023890.md) | [(659) d](/filings/0001493152-26-036637.md) | [(1,620) d](/filings/0001493152-25-023549.md) | [(9,694) d](/filings/0001493152-26-016664.md) | [(4,692)](/filings/0001493152-26-023890.md) | [(5,006) d](/filings/0001493152-26-036637.md) |
| Capital expenditure | $k | [3.4 d](/filings/0001493152-23-041316.md) | not reported | not reported | not reported | [(4.7) d](/filings/0001493152-25-023549.md) | [(0.4) d](/filings/0001493152-26-016664.md) | [0.2](/filings/0001493152-26-023890.md) | [2.1 d](/filings/0001493152-26-036637.md) | [0.0 d](/filings/0001493152-25-023549.md) | [0.0 d](/filings/0001493152-26-016664.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [30.0](/filings/0001493152-23-041316.md) | [1.2](/filings/0001493152-24-032436.md) | [2.5](/filings/0001493152-24-032440.md) | [0.7](/filings/0001493152-24-046025.md) | [1.4](/filings/0001641172-25-011052.md) | [2.1](/filings/0001493152-25-012159.md) | [1.8](/filings/0001493152-25-023549.md) | [3.0](/filings/0001493152-26-023890.md) | [3.0](/filings/0001493152-26-036637.md) | [44.7](/filings/0001493152-25-023549.md) | [241](/filings/0001493152-26-023890.md) | [399](/filings/0001493152-26-036637.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 429,777,400 at 2026-08-07, from the cover of the [10-Q filed 2026-08-07](/filings/0001493152-26-036637.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.